Involvement of nitric oxide in the pathogenesis of cyclophosphamide- induced hemorrhagic cystitis

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 247-256

  Souza Filho, Marcus Vinícius Ponte ^a   Lima, Marcos Venício Alves ^a   Pompeu, Margarida Maria Lima ^a   Ballejo, Gustavo ^b   Cunha, Fernando Queiroz ^b   De Ribeiro, Ronaldo Albuquerque ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE TIME EFFECT RELATION; EXTRAVASATION; HEMORRHAGIC CYSTITIS; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CYCLOPHOSPHAMIDE; CYSTITIS; ENZYME INDUCTION; HEMORRHAGE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR;

EID: 0031021650     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Philips FS, Sternberg SS, Cronin AP, Vidai PM: Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961, 21:1577-1589
2. Stillwell TJ, Benson RC: Cyclophosphamide-induced hemorrhagic cystitis: a review of 100 patients. Cancer 1988, 61:451-457
3. Foad BSI, Hess EU: Urinary bladder complications with cyclophosphamide therapy. Arch Intern Med 1976, 136:616-625
4. Droller MJ, Saral R, Santos G: Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982, 20:256-258
5. Cox PJ: Cyclophosphamide cystitis: identification of acrolein as the causative agent. Biochem Pharmacol 1979, 28:2045-2049
6. Forstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F: Isoforms of nitric oxide synthase: characterization and purification from different cell types, Biochem Pharmacol 1991, 42:1849-1857
7. Nathan CF: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6:3051-3064
8. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142
9. Estrada C, Gómez C, Martín C, Moncada S, González C: Nitric oxide mediates tumor necrosis factor-α cytotoxicity in endothelial cells. Biochem Biophys Res Commun 1992, 186:475-482
10. lalenti A, lanaro A, Moncada S, Di Rosa M: Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992, 211:177-182
11. lalenti A, Moncada S, Di Rosa M: Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993, 110:701-706
12. Mulligan MS, Hevel JM, Marietta MA, Ward PA: Tissue injury caused by deposition of immune complexes is I-arginine dependent. Proc Natl Acad Sci USA 1991, 88:6338-6342
13. Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993, 341:465-466
14. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA: Amelioration of chronic ileitis by nitric oxide synthase inhibition, J Pharmacol Exp Ther 1993, 264:11-16
15. Parrel AJ, Blake DR, Palmer RMJ, Moncada S: Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992, 51:1219-1222
16. Braquet P, Touqui L, Shen TY, Vargaítig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 1987, 39:97-145
17. Snyder F: Platelet-activating factor and related acetylated lipids as potent biologically active mediators. Am J Physiol 1990, 259:C697-C708
18. Szabó C, Wu CC, Mitchell JA, Gross SS, Thiemermann C, Vane JR: Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993, 73:991-999
19. Gomes TNA, Santos CG, Souza-Filho MVP, Cunha FQ, Ribeiro RA: Participation of TNF-α and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Brazilian J Med Biol Res 1995, 28:11031108
20. Salter M, Knowles RG, Moncada S: Widespread tissue distribution, species distribution, and changes in activity of calcium-dependent and calcium-independent nitric oxide synthases, FEBS Lett 1991, 291:145-149
21. Assreuy J, Cunha FQ, Liew FY, Moncada S: Feedback inhibition of nitric oxide. Br J Pharmacol 1993, 108:833-837
22. Hope BT, Vincent SR: Histochemical characterization of neuronal NADPH diaphorase. J Histochem Cytochem 1989, 37:653-661
23. Gray KJ, Engelmann UH, Johnson EH, Fishman IJ: Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol 1986, 133:497-500
24. Nava E, Palmer RMJ, Moncada S: The role of nitric oxide in endotoxic shock. Biology of Nitric Oxide: Physiological and Clinical Aspects, Edited by S Moncada, MA Marietta, JB Hibbs, EA Higgs. London, Portland Press, 1992, pp 231-233
25. Hughes SR, Williams TJ, Brain SD: Evidence that nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 1990, 191:481-484
26. Antunes E, Mariano M, Cirino G, Levi S, de Nucci G: Pharmacological characterization of polycation-induced rat-hind paw oedema. Br J Pharmacol 1990, 101:986-990
27. Antunes E, Giraldelo CMM, Cirino G, de Nucci G: Effects of NG-monomethyl-L-arginine and its D-enantiomer on rat hind paw oedema. Biology of Nitric Oxide: Physiological and Clinical Aspects. Edited by S Moncada, MA Marietta, JB Hibbs, EA Higgs, London, Portland Press, 1992, pp 264-266
28. Mayhan WG: Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5-diphosphate and bradykinin. Inflammation 1992, 16:295-305
29. Wei X, Charles IG, Smith A, Ure J, Feng GF, Huang F, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411